Feedback / Questions
glenzocimab (ACT 017) - Acticor Biotech
http://clinicaltrials.gov/ct2/show/NCT05070260
Dec 6, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next